Logo image of NBLX

Noble Midstream Partners LP (NBLX) Stock Fundamental Analysis

NYSE:NBLX -

15.21
-0.09 (-0.59%)
Last: 5/10/2021, 8:21:48 PM
15.21
0 (0%)
After Hours: 5/10/2021, 8:21:48 PM
Fundamental Rating

2

NBLX gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 0 industry peers in the Unkown industry. NBLX has a bad profitability rating. Also its financial health evaluation is rather negative. NBLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

NBLX had positive earnings in the past year.

1.2 Ratios

Industry RankSector Rank
ROA 5.11%
ROE 13%
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Industry RankSector Rank
OM 29.94%
PM (TTM) 18.94%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

More info and screens

1

2. Health

2.1 Basic Checks

There is no outstanding debt for NBLX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.

2.2 Solvency

NBLX has an Altman-Z score of 0.69. This is a bad value and indicates that NBLX is not financially healthy and even has some risk of bankruptcy.
NBLX has a Debt/Equity ratio of 0.89. This is a neutral value indicating NBLX is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 0.69
ROIC/WACCN/A
WACCN/A

2.3 Liquidity

A Current Ratio of 0.25 indicates that NBLX may have some problems paying its short term obligations.
NBLX has a Quick Ratio of 0.25. This is a bad value and indicates that NBLX is not financially healthy enough and could expect problems in meeting its short term obligations.
Industry RankSector Rank
Current Ratio 0.25
Quick Ratio 0.25

More info and screens

4

3. Growth

3.1 Past

The earnings per share for NBLX have decreased strongly by -12.01% in the last year.
Measured over the past years, NBLX shows a very strong growth in Earnings Per Share. The EPS has been growing by 32.10% on average per year.
The Revenue has been growing slightly by 6.75% in the past year.
Measured over the past years, NBLX shows a very strong growth in Revenue. The Revenue has been growing by 54.15% on average per year.
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%

3.2 Future

The Earnings Per Share is expected to decrease by -11.14% on average over the next years. This is quite bad
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NBLX Yearly Revenue VS EstimatesNBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
NBLX Yearly EPS VS EstimatesNBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 5.61, the valuation of NBLX can be described as very cheap.
NBLX is valuated cheaply when we compare the Price/Earnings ratio to 27.08, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 6.82, which indicates a rather cheap valuation of NBLX.
NBLX is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.67, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
NBLX Price Earnings VS Forward Price EarningsNBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA 6.85
NBLX Per share dataNBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

A cheap valuation may be justified as NBLX's earnings are expected to decrease with -11.14% in the coming years.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 4.93%, NBLX is a good candidate for dividend investing.
Compared to an average S&P500 Dividend Yield of 2.34, NBLX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.93%

5.2 History

The dividend of NBLX decreases each year by -19.17%.
NBLX has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-19.17%
Div Incr YearsN/A
Div Non Decr YearsN/A
NBLX Yearly Dividends per shareNBLX Yearly Dividends per shareYearly Dividends per share 2017 2018 2019 2020 2021 0.5 1 1.5 2 2.5

5.3 Sustainability

NBLX's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP0%
EPS Next 2Y-11.14%
EPS Next 3YN/A

More info and screens

Noble Midstream Partners LP

NYSE:NBLX (5/10/2021, 8:21:48 PM)

After market: 15.21 0 (0%)

15.21

-0.09 (-0.59%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)02-11 2022-02-11/bmo
Inst Owners2.19%
Inst Owner Change0%
Ins Owners37.49%
Ins Owner Change0%
Market Cap1.37B
Analysts46.6
Price Target13.9 (-8.61%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 4.93%
Yearly Dividend0.75
Dividend Growth(5Y)-19.17%
DP0%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 5.61
Fwd PE 6.82
P/S 1.68
P/FCF N/A
P/OCF N/A
P/B 1.15
P/tB N/A
EV/EBITDA 6.85
EPS(TTM)2.71
EY17.82%
EPS(NY)2.23
Fwd EY14.66%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS9.06
BVpS13.21
TBVpSN/A
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 5.11%
ROE 13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM 29.94%
PM (TTM) 18.94%
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y0%
ROICexcg growth 5Y0%
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.27
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.25
Quick Ratio 0.25
Altman-Z 0.69
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-12.01%
EPS 3YN/A
EPS 5Y32.1%
EPS Q2Q%-32.31%
EPS Next Y-17.71%
EPS Next 2Y-11.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6.75%
Revenue growth 3YN/A
Revenue growth 5Y54.15%
Sales Q2Q%24.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A